HK1093064A1 - Thienopyrimidine derivatives as potassium channel inhibitors - Google Patents

Thienopyrimidine derivatives as potassium channel inhibitors

Info

Publication number
HK1093064A1
HK1093064A1 HK06110995.8A HK06110995A HK1093064A1 HK 1093064 A1 HK1093064 A1 HK 1093064A1 HK 06110995 A HK06110995 A HK 06110995A HK 1093064 A1 HK1093064 A1 HK 1093064A1
Authority
HK
Hong Kong
Prior art keywords
potassium channel
channel inhibitors
thienopyrimidine derivatives
thienopyrimidine
derivatives
Prior art date
Application number
HK06110995.8A
Other languages
English (en)
Inventor
John Ford
Nicholas John Palmer
John Frederick Atherall
David John Madge
Brad Sherborne
Mark Bushfield
Edward Benedict Stevens
Original Assignee
Xention Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0315950.6A external-priority patent/GB0315950D0/en
Application filed by Xention Discovery Ltd filed Critical Xention Discovery Ltd
Publication of HK1093064A1 publication Critical patent/HK1093064A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK06110995.8A 2003-06-11 2006-10-04 Thienopyrimidine derivatives as potassium channel inhibitors HK1093064A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47751803P 2003-06-11 2003-06-11
GBGB0315950.6A GB0315950D0 (en) 2003-06-11 2003-06-11 Compounds
PCT/GB2004/002454 WO2004111057A1 (en) 2003-06-11 2004-06-10 Thienopyrimidine derivatives as potassium channel inhibitors

Publications (1)

Publication Number Publication Date
HK1093064A1 true HK1093064A1 (en) 2007-02-23

Family

ID=33554173

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06110995.8A HK1093064A1 (en) 2003-06-11 2006-10-04 Thienopyrimidine derivatives as potassium channel inhibitors

Country Status (16)

Country Link
EP (1) EP1641803B3 (de)
KR (1) KR101186678B1 (de)
CN (1) CN1823071B (de)
AT (1) ATE425982T1 (de)
AU (1) AU2004247470B2 (de)
BR (1) BRPI0411239A (de)
CA (1) CA2528848C (de)
DE (1) DE602004020070D1 (de)
DK (1) DK1641803T3 (de)
ES (1) ES2324536T7 (de)
HK (1) HK1093064A1 (de)
MX (1) MXPA05013549A (de)
PL (1) PL1641803T6 (de)
SI (1) SI1641803T1 (de)
WO (1) WO2004111057A1 (de)
ZA (1) ZA200600225B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0315950D0 (en) 2003-06-11 2003-08-13 Xention Discovery Ltd Compounds
JP2008505084A (ja) 2004-06-29 2008-02-21 アムゲン インコーポレイティッド フラノピリミジン
CN101084224B (zh) * 2004-10-21 2013-12-04 美国陶氏益农公司 具有杀真菌活性的噻吩并-嘧啶化合物
US7576212B2 (en) 2004-12-09 2009-08-18 Xention Limited Thieno[2,3-B] pyridines as potassium channel inhibitors
US7576080B2 (en) 2004-12-23 2009-08-18 Memory Pharmaceuticals Corporation Certain thienopyrimidine derivatives as phosphodiesterase 10 inhibitors
EP1922311A2 (de) 2005-09-09 2008-05-21 Brystol-Myers Squibb Company Azyklische ikur-hemmer
GB0525164D0 (en) 2005-12-09 2006-01-18 Xention Discovery Ltd Compounds
DE102007027800A1 (de) 2007-06-16 2008-12-18 Bayer Healthcare Ag Substituierte bicyclische Heteroaryl-Verbindungen und ihre Verwendung
WO2010048287A2 (en) 2008-10-22 2010-04-29 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Radioprotective agents
WO2010103130A2 (en) 2009-03-13 2010-09-16 Katholieke Universiteit Leuven, K.U.Leuven R&D Novel bicyclic heterocycles
LT3575288T (lt) 2009-09-03 2021-12-10 Bristol-Myers Squibb Company Chinazolinai kaip kalio jonų kanalų inhibitoriai
SG183304A1 (en) * 2010-02-17 2012-09-27 Takeda Pharmaceutical Heterocyclic compound
GB201012889D0 (en) 2010-08-02 2010-09-15 Univ Leuven Kath Antiviral activity of novel bicyclic heterocycles
GB201015411D0 (en) 2010-09-15 2010-10-27 Univ Leuven Kath Anti-cancer activity of novel bicyclic heterocycles
WO2012044993A1 (en) * 2010-09-30 2012-04-05 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Compounds, pharmaceutical compositions, and methods of treating or preventing neurodegenerative diseases or disorders
GB201105659D0 (en) 2011-04-01 2011-05-18 Xention Ltd Compounds
NO3175985T3 (de) 2011-07-01 2018-04-28
US20140357662A1 (en) * 2011-11-15 2014-12-04 Xention Limited Thieno (2,3 - c) pyrazoles for use as potassium channel inhibitors
AR090037A1 (es) * 2011-11-15 2014-10-15 Xention Ltd Derivados de tieno y/o furo-pirimidinas y piridinas inhibidores de los canales de potasio
EP3048106B1 (de) 2011-11-23 2019-11-06 Cancer Research Technology Limited Thienopyrimidinverbindungen als inhibitoren von atypischer proteinkinase c
CA2862670A1 (en) 2012-01-27 2013-08-01 Gilead Sciences, Inc. Combination therapies using late sodium ion channel blockers and potassium ion channel blockers
WO2014134419A1 (en) 2013-03-01 2014-09-04 Gilead Sciences, Inc. Use of ikach blockers for the treatment of cardiac diseases
WO2014138562A1 (en) * 2013-03-07 2014-09-12 Glaxosmithkline Llc Thieno[3,2-d]pyrimidine-6-carboxamides and analogues as sirtuin modulators
FR3015483B1 (fr) * 2013-12-23 2016-01-01 Servier Lab Nouveaux derives de thienopyrimidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN106727587A (zh) * 2016-11-28 2017-05-31 李娜 一种治疗心律失常的药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD248593A1 (de) * 1985-01-11 1987-08-12 Univ Halle Wittenberg Verfahren zur herstellung von 4-basischsubstituierten thieno/2,3-d/pyrimidin-6-ylcarbonsaeureestern
EP1240147A1 (de) * 1999-12-21 2002-09-18 Icagen, Inc. Kaliumkanalblocker
US6566380B2 (en) * 2000-07-25 2003-05-20 Icagen, Inc. Potassium channel inhibitors
US6849634B2 (en) * 2000-12-21 2005-02-01 Icagen Potassium channel inhibitors

Also Published As

Publication number Publication date
CN1823071B (zh) 2012-12-19
DE602004020070D1 (de) 2010-10-07
EP1641803B3 (de) 2010-12-08
ES2324536T3 (es) 2009-08-10
AU2004247470B2 (en) 2009-04-23
ZA200600225B (en) 2007-04-25
SI1641803T1 (sl) 2009-08-31
CN1823071A (zh) 2006-08-23
ES2324536T7 (es) 2012-03-16
PL1641803T6 (pl) 2011-04-29
DK1641803T3 (da) 2009-06-29
EP1641803A1 (de) 2006-04-05
MXPA05013549A (es) 2006-04-05
ATE425982T1 (de) 2009-04-15
KR101186678B1 (ko) 2012-09-27
EP1641803B1 (de) 2009-03-18
PL1641803T3 (pl) 2009-08-31
KR20060057539A (ko) 2006-05-26
AU2004247470A1 (en) 2004-12-23
BRPI0411239A (pt) 2006-07-18
CA2528848C (en) 2012-09-04
WO2004111057A1 (en) 2004-12-23
CA2528848A1 (en) 2004-12-23

Similar Documents

Publication Publication Date Title
HK1093064A1 (en) Thienopyrimidine derivatives as potassium channel inhibitors
IL260127B (en) mek inhibitors and methods of using them
SG164368A1 (en) Treatment of cancer
TW200508214A (en) Novel compounds
MY149957A (en) Heterocyclic inhibitors of mek and methods of use thereof
GB2430935A (en) Tetrapeptide analogs
TW200740803A (en) Heterocyclic derivatives as modulators of ion channels
MY161991A (en) Proteasome inhibitors
IL181271A0 (en) Triazolophthalazine derivatives and pharmaceutical compositions containing the same
CA2603830A1 (en) PYRIDINE [2,3-B] PYRAZINONES
WO2006050476A3 (en) Pyrimidine derivatives as ion channel modulators and methods of use
ZA200710332B (en) Bicyclic derivatives as modulators of ion channels
TW200600087A (en) Methods and compositions for treating amyloid-related diseases
MXPA05014166A (es) Metodos y composiciones para tratar enfermedades relacionadas con amiloide.
PL1654253T3 (pl) Podstawione pochodne 3-pirolidynoindolu
IL205696A0 (en) Heterocyclic derivatives, compositions comprising the same and uses thereof
EP1551388A4 (de) Nützliche verbindungen für die behandlung von krebs, zusammensetzungen daraus und verfahren damit
AU2003270202A8 (en) Pharmaceutical compositions useful for the treatment of cancers
JO3046B1 (ar) اشكال متعددة من 7- )] 3-كلورو-6و11-ثنائي هيدرو -6-ميثيل ثنائي بنزو [1, 2][f,c] ثيازبين-11-يل)امينو[ حمض هباتونك S,S- ثنائي أوكسيد وطرق لتصنيعها و استخدامها.
TW200714284A (en) Novel method
UA96742C2 (en) Mek inhibitors and use thereof
ZA200605653B (en) Proline derivatives used as pharmaceutical active ingredients for the treatment of tumours
MY180594A (en) Proteasome inhibitors

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20160610